Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Armstrong

Showing results (801-810 of 1,035) with videos related to

Pageof 104
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|August 12, 2023
Microfibrous Scaffolds Guide Stem Cell Lumenogenesis and Brain Organoid EngineeringKaja I Ritzau-Reid, Sebastien J P Callens, Ruoxiao Xie, et al.
Microbial Genomics|March 29, 2023
Travel-associated lineages and unique endemic antimicrobial-susceptible lineages of <i>Neisseria gonorrhoeae</i> predominate in Western AustraliaBarakat A Al Suwayyid, Ethan C Haese, Shakeel Mowlaboccus, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's diseasePeter R Baker, Erin E Baschal, Pam R Fain, et al.
Clinical Breast Cancer|February 6, 2010
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancerSaranya Chumsri, Stacie Jeter, Lisa K Jacobs, et al.
Annals of the Rheumatic Diseases|May 22, 2010
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))P Emery, A Deodhar, W F Rigby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group studyS O'Reilly, G F Fleming, S D Barker, et al.
The British Journal of Dermatology|December 3, 2020
Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneityR Laskar, A Ferreiro-Iglesias, D T Bishop, et al.
Burns : Journal of the International Society for Burn Injuries|April 6, 2024
A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model - A pilot studyRoss I Donaldson, Jonathan K Armstrong, Oliver J Buchanan, et al.
The Journal of Investigative Dermatology|March 14, 2009
Evaluation of the clonal origin of multiple primary melanomas using molecular profilingIrene Orlow, Diana V Tommasi, Bradley Bloom, et al.
Breast Cancer Research and Treatment|February 9, 2013
A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitorsTing Bao, Ling Cai, Jon T Giles, et al.
Pageof 104

Showing results (801-810 of 1,035) with videos related to

Sort By:
Pageof 104
Advanced Materials (Deerfield Beach, Fla.)|August 12, 2023
Microfibrous Scaffolds Guide Stem Cell Lumenogenesis and Brain Organoid EngineeringKaja I Ritzau-Reid, Sebastien J P Callens, Ruoxiao Xie, et al.
Microbial Genomics|March 29, 2023
Travel-associated lineages and unique endemic antimicrobial-susceptible lineages of <i>Neisseria gonorrhoeae</i> predominate in Western AustraliaBarakat A Al Suwayyid, Ethan C Haese, Shakeel Mowlaboccus, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's diseasePeter R Baker, Erin E Baschal, Pam R Fain, et al.
Clinical Breast Cancer|February 6, 2010
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancerSaranya Chumsri, Stacie Jeter, Lisa K Jacobs, et al.
Annals of the Rheumatic Diseases|May 22, 2010
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))P Emery, A Deodhar, W F Rigby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group studyS O'Reilly, G F Fleming, S D Barker, et al.
The British Journal of Dermatology|December 3, 2020
Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneityR Laskar, A Ferreiro-Iglesias, D T Bishop, et al.
Burns : Journal of the International Society for Burn Injuries|April 6, 2024
A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model - A pilot studyRoss I Donaldson, Jonathan K Armstrong, Oliver J Buchanan, et al.
The Journal of Investigative Dermatology|March 14, 2009
Evaluation of the clonal origin of multiple primary melanomas using molecular profilingIrene Orlow, Diana V Tommasi, Bradley Bloom, et al.
Breast Cancer Research and Treatment|February 9, 2013
A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitorsTing Bao, Ling Cai, Jon T Giles, et al.
Pageof 104